Correlation Between Fonar and Aclaris Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fonar and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fonar and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fonar and Aclaris Therapeutics, you can compare the effects of market volatilities on Fonar and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fonar with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fonar and Aclaris Therapeutics.

Diversification Opportunities for Fonar and Aclaris Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fonar and Aclaris is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Fonar and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Fonar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fonar are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Fonar i.e., Fonar and Aclaris Therapeutics go up and down completely randomly.

Pair Corralation between Fonar and Aclaris Therapeutics

Given the investment horizon of 90 days Fonar is expected to generate 20.49 times less return on investment than Aclaris Therapeutics. But when comparing it to its historical volatility, Fonar is 3.25 times less risky than Aclaris Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,518  in Aclaris Therapeutics on August 28, 2024 and sell it today you would lose (1,119) from holding Aclaris Therapeutics or give up 73.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fonar  vs.  Aclaris Therapeutics

 Performance 
       Timeline  
Fonar 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fonar has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Fonar is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Aclaris Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Fonar and Aclaris Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fonar and Aclaris Therapeutics

The main advantage of trading using opposite Fonar and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fonar position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.
The idea behind Fonar and Aclaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios